Norwegian VoluSense won NOME’s first life science start-up competition

The Norwegian medtech and diagnostics company VoluSense – a developer of non-invasive, non-sedative and mask-free respiratory monitoring systems for lung function evaluation, was announced as the final winner of NOME's first life science start-up competition.

NOME, the Nordic Mentor Network for Entrepreneurship, is an elite mentoring program aiming to develop and implement a best-in-class mentoring initiative for high-growth life science start-ups. Its ambition is to position the Nordic countries as a leader in life science. NOME matches Nordic projects and start-ups with highly skilled volunteer professionals to help them reach their goals and technology milestones.

NOME is operated by Accelerace Management, the Danish representative in the network. Turku Science Park Ltd. coordinates the NOME-programme in Finland.

NOME held its first annual meeting on October 24, 2017 in Copenhagen. “The day was dedicated to celebrating our first year of adding value to life science start-ups, and to welcome the winner of the elite NOME start-up competition,” said Kirsten Drejer, NOME Mentor & Co-founder and former CEO of Symphogen, now board member of 6 life science companies.

The competing start-ups, among them five from Finland, were scrutinized in detail and reduced to ten candidates selected by the partners and presented to an expert panel. These were further reduced to three finalists who were presented to a panel of NOME mentors. NOME mentors include world class professionals from all over the Nordics with diverse backgrounds such as serial entrepreneurs, investors, clinical experts and representatives from larger biotech/pharma and medtech companies

The Norwegian medtech and diagnostics company VoluSense – a developer of non-invasive, non-sedative and mask-free respiratory monitoring systems for lung function evaluation, was announced as the final winner of the competition.